Search Result

• All
• Related Products
• Other Content

• Center for Drug Evaluation (CDE) Issued the Notification of “Technical Guideline for the Clinical Risk Management Plan for Marketing Application of Chimeric Antigen Receptor T cell (CAR-T) Therapy Pro Chimeric antigen receptor CAR-T cells (CAR-T) refer to a type of T cell that can recognize a specific antigen by introducing vectors such as viruses into autologous or allogeneic T cells through gene ... More+
• Study Confirms Safety and Efficiency of Optimized K562 Feeder Cells for NK Cell Expansion Study Confirms Safety and Efficiency of Optimized K562 Feeder Cells for NK Cell ExpansionA new study published in the Annals of Laboratory Medicine (2025) has reported significant progress in the opti... More+
• Instructions for Use of E.coli Residual Total RNA Detection Kit (RT-qPCR)
• Who will become the leading “water supplier” during the “gold rush” of the cellular therapy industry? 2022 marks the 10th anniversary of Emily Whitehead, the world's first child with leukemia cured by CAR-T cell immunotherapy, achieving cancer-free survival.In 2012, Emily, who suffered from acute ... More+
• Bayer Advances Parkinson’s Stem Cell Therapy into Phase III Clinical Trial On September 22, 2025, Reuters reported that Bayer’s subsidiary BlueRock Therapeutics has officially initiated a Phase III clinical trial of its experimental stem cell therapy for Parkinson’s diseas... More+
• Instructions for Use of E.coli Residual Total RNA Sample Preprocessing Kit
• The Comprehensive Affairs Department of NMPA Solicits Public Comments on “Key Points for Inspection of Drug Product MAHs (Draft for Comments)” In order to strengthen the supervision and management of drug marketing authorization holders (hereinafter referred to as holders), supervise the holders to fulfill the quality management responsibili... More+
• French Biotech Allogenica Secures €2.5M Grant to Advance Universal CAR-T Therapy Industrialization Allogenica, a biotechnology company based in Lyon, has secured €2.5 million in funding from the French government’s France 2030 strategic investment program. The grant will accelerate the industrial... More+
• CDMO Services for Lentiviral Vectors-Clinical Grade Lentivirus, a subtype of retrovirus, can integrate the target gene into the host cell genome, and is commonly used as a viral vector for ex vivo cell engineering. With the emergence of cellular therap... More+
• Instructions for Use of E1A Residual DNA Detection Kit (qPCR)
• Center for Drug Evaluation (CDE) Issued the Notification of “Technical Guideline for the Evaluation of Immune-related Adverse Events in Antitumor Therapy” (No. 25, 2022) Tumor immunotherapy is a hot topic in the current research and development of new anti-tumor drugs. How to improve the scientificity and robustness of the identification and judgment of immune-related... More+
• AstraZeneca and Algen Biotechnologies Forge $555 Million Gene Therapy Collaboration October 6, 2025 — San Francisco, USA – AstraZeneca announced a strategic collaboration and licensing agreement with Algen Biotechnologies, a U.S.-based biotech company specializing in AI-driven gene... More+
• Instructions for Use of E1A & SV40LTA Residual DNA Detection Kit (Multiplex qPCR)
• Hillgene Winning the Bid on the First Contract Manufacturing Order for Commercial CAR-T Cell Therapy in China It is reported that Shanghai Xianbo Biotechnology Co., Ltd. and Jiangsu Puxin Biopharmaceutical Co., Ltd. have reached a strategic cooperation agreement, entrusting Puxin Bio to carry out the second p... More+
• Hillgene Takes Note of FDA New Guidelines: Interpreting the Latest Developments and Industry Opportunities in Cross-Border Genetic Data Research The U.S. Food and Drug Administration (FDA) recently issued an important announcement stating it will pause new clinical trial applications led by U.S. institutions that involve sending cells from U.S... More+